74 completed, 63 unknown, 55 recruiting, 29 not yet recruiting. 88 Phase 2, 73 Not applicable, 28 Phase 3, 20 Phase 1, 5 Phase 4.
Follow Chemotherapy: new trials by email Literature Review of Chemotherapy trials Research Report on Chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer Short-course radiotherapy, Capecitabine, Oxaliplatin - Rectal Cancer, Radiotherapy | Phase 2 | Not yet recruiting | Tao Zhang | 144 | 2026-11-01 | 2026-10-06 |
| A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During Surgical Procedures Panitumumab-IRDye800 - Cancer, Chemotherapy | Phase 1 | Not yet recruiting | University of Alabama at Birmingham | 6 | 2026-11-01 | 2026-11-05 |
| Antibody-Drug Conjugate Plus Immunotherapy Versus Immunotherapy Plus Chemotherapy for Extensive Transurethrally Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer Disitamab Vedotin and Toripalimab, Toripalimab and Nab-Paclitaxel - Bladder (Urothelial, Transitional Cell) Cancer, Antibody-drug Conjugates | Phase 2 | Not yet recruiting | Tianjin Medical University Second Hospital | 150 | 2026-10-20 | 2026-10-23 |
| Gait Parameters in Breast Cancer Receiving Chemotherapy Patients Gait parameter assessment - Breast Cancer, Chemotherapy | Recruiting | Adly A Adam | 360 | 2026-10-01 | 2026-10-26 | |
| Effect of Gamified Sun Protection Education Provided to Chemotherapy Patients Gamified education - Chemotherapy, Sun Protection | Not applicable | Not yet recruiting | Lokman Hekim University | 54 | 2026-09-30 | 2026-09-10 |
| Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy Aromatherapy, Standard triple antiemetic therapy - Breast Cancer, Aromatherapy | Phase 3 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 374 | 2026-08-18 | 2026-08-12 |
| Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma Iparomlimab and tuvonralimab injection (QL1706) + Lenvatinib + EP/EC, EP/EC - Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), QL1706 | Phase 2 | Not yet recruiting | West China Hospital | 92 | 2026-08-01 | 2026-07-31 |
| Effect of AI-Assisted Expressive Writing on Anxiety, Emotional Distress, and Quality of Life Among Patients Receiving Chemotherapy AI-Assisted Expressive Writing, Active Comparator: Routine Care Group - Cancer, Chemotherapy | Not applicable | Not yet recruiting | Alexandria University | 100 | 2026-07-10 | 2026-07-20 |
| Quality of Life of Patients Who Have Undergone Bilateral Mastectomy Surgery Date, Age | Not yet recruiting | University Hospital, Grenoble | 115 | 2026-07-10 | 2026-07-15 | |
| Chemo Brain Prehab Project Exercise Prehabilitation, Multivitamins, Standard Care (in control arm) - Colorectal Cancer, Older Adults (60 - 85 Years Old) | Not applicable | Recruiting | Dr. Chris Gaffney | 86 | 2026-07-07 | 2026-09-09 |
| Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity Sotagliflozin, Placebo - Anthracycline-induced Cardiotoxicity, Lymphoma | Phase 2 | Not yet recruiting | Icahn School of Medicine at Mount Sinai | 60 | 2026-07-01 | 2026-05-07 |
| Effect of Virtual Reality-Guided Imagery on Pain, Anxiety, and Fatigue in Cancer Patients Undergoing Chemotherapy Virtual Reality-Guided Imagery - Virtual Reality, Guided Imagery | Not applicable | Not yet recruiting | Thoalfokar Mohammed Al-Obaidi | 108 | 2026-07-01 | 2026-06-30 |
| Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer True electroacupuncture, True thumbtack needle, Sham electroacupuncture - Electroacupuncture, Chemotherapy | Not applicable | Not yet recruiting | Affiliated Hospital of Qinghai University | 264 | 2026-05-25 | 2026-06-12 |
| Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Early-stage Cancer True electroacupuncture, True thumbtack needle, Sham electroacupuncture - Electroacupuncture, Chemotherapy | Not applicable | Not yet recruiting | Affiliated Hospital of Qinghai University | 278 | 2026-05-25 | 2026-06-23 |
| Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel Sesame Oil, Aloe vera gel, Control - Cancer, Chemotherapy | Phase 2 | Not yet recruiting | University of Basrah | 190 | 2026-05-11 | 2026-04-28 |
| Chemotherapy-Induced Hearing Loss and Health Inequality Cancer, Chemo Brain | Recruiting | Lancaster University | 172 | 2026-05-02 | 2026-09-10 | |
| Individualized Care Perceptions of Patients Receiving Outpatient Chemotherapy: A Qualitative Study Cancer Patients, Care | Not yet recruiting | University of Yalova | 10 | 2026-05-01 | 2026-04-23 | |
| Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC Tislelizumab, Intravenous Chemotherapy, Bronchial Artery Chemoembolization (BACE) - Unresectable Stage III Non-small Cell Lung Cancer, Tislelizumab | Phase 2 | Not yet recruiting | Sichuan Cancer Hospital and Research Institute | 39 | 2026-05-01 | 2026-05-01 |
| Investigation of Digital Media Use in Patients Receiving Chemotherapy No Intervention (Observational Study) - Cancer, Chemotherapy | Not yet recruiting | Fenerbahce University | 80 | 2026-04-20 | 2026-04-21 | |
| Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2 Tislelizumab, Becotatug Vedotin, Cisplatin - ESCC, Tislelizumab | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 93 | 2026-04-01 | 2026-04-15 |
Showing 20 of 240. Sign in to see all of them.
Neoplasms (46) · Breast Neoplasms (32) · Colorectal Neoplasms (19) · Anxiety Disorders (11) · Neoplasm Metastasis (10) · Motor Activity (9) · Stomach Neoplasms (9) · Carcinoma, Non-Small-Cell Lung (7) · Ovarian Neoplasms (7) · Uterine Cervical Neoplasms (7) · Anemia (6) · Nasopharyngeal Carcinoma (6) · Colonic Neoplasms (5) · Esophageal Neoplasms (5) · Fatigue (5)
Neoplasms (133) · Neoplasms by Site (125) · Digestive System Diseases (52) · Digestive System Neoplasms (50) · Pathological Conditions, Signs and Symptoms (49) · Gastrointestinal Diseases (47) · Gastrointestinal Neoplasms (42) · Skin Diseases (32) · Skin and Connective Tissue Diseases (32) · Breast Diseases (31) · Neoplasms by Histologic Type (30) · Signs and Symptoms (27) · Intestinal Diseases (26) · Intestinal Neoplasms (26) · Pathologic Processes (25)
Drug Therapy (24) · Cisplatin (9) · Docetaxel (8) · Fluorouracil (8) · Oxaliplatin (8) · Immune Checkpoint Inhibitors (7) · Capecitabine (6) · Epoetin Alfa (6) · Bevacizumab (5) · Chemoradiotherapy (5) · Leucovorin (5) · toripalimab (5) · Carboplatin (4) · Folfox protocol (4) · S 1 (combination) (4)
Sun Yat-sen University (11) · Fudan University (6) · Lei Li (6) · Jiuda Zhao (4) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (3) · Chinese Academy of Medical Sciences (3) · Guangdong Provincial People's Hospital (3) · Henan Cancer Hospital (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (3) · Affiliated Hospital of Qinghai University (2) · Ain Shams University (2) · Centre Hospitalier Universitaire, Amiens (2) · Chinese PLA General Hospital (2) · Harbin Medical University (2)
China (90) · United States (21) · Turkey (Türkiye) (20) · France (17) · Taiwan (9) · Egypt (6) · Germany (6) · Spain (4) · Sweden (4) · Denmark (3) · Italy (3) · Switzerland (3) · United Kingdom (3) · Belgium (2) · Brazil (2)
Lei Li, M.D. (6) · Huajun Jin (2) · Jiangtao Wang (2) · Jianping Xiao, Dr (2) · Nehman Makdissy, Professor (2) · Qijun Qian (2) · Salah Dine Qanadli, Prof. MD PhD (2) · Scott D. Halpern, MD, PhD (2) · Xiaonan Hong, MD (2) · Yun-fei Xia, MD (2) · Zhenyu Lin (2) · Abdel Halim, PhD, PharmD (1) · Alejandro De la Torre, MD (1)
PMID 30207593, PMID 11230497, PMID 11481354, PMID 11489791, PMID 11895891, PMID 12457622, PMID 12771885, PMID 14736927, PMID 14749623, PMID 15135924, PMID 16133789, PMID 16177289, PMID 16271446, PMID 1651156, PMID 16638478, PMID 16977654, PMID 17131349, PMID 17468871, PMID 17954800, PMID 19349540, PMID 19425235, PMID 19786984, PMID 19826112, PMID 20049561, PMID 20410061, PMID 20529041, PMID 20622770, PMID 21073761, PMID 21218740, PMID 21471870, PMID 21600374, PMID 22082029, PMID 22211087, PMID 22404338, PMID 22416039, PMID 22583935, PMID 22619725, PMID 22811849, PMID 23372097, PMID 23406728, PMID 23563998, PMID 23880820, PMID 23955585, PMID 23978939, PMID 24118635, PMID 24166522, PMID 24373830, PMID 24407899, PMID 24607558, PMID 24777126
2016 (2), 2018 (1), P30CA012197 (1), R37CA242545 (1)